Plasticity of fibroblasts demonstrated by tissue-specific and function-related proteome profiling

Clinical Proteomics

Christopher Gerner⁴  Verena Paulitschke³  Hendrik Jan Ankersmit²  Agnes Beer⁴  Anastasia Meshcheryakova⁴  Astrid Slany¹ 

[1] Faculty of Chemistry, Department of Analytical Chemistry, University of Vienna, Vienna, Austria;Department of Thoracic Surgery, Division of Surgery, Medical University Vienna, Vienna, Austria; Christian Doppler Laboratory for the Diagnosis and Regeneration of Cardiac and Thoracic Diseases, Medical University Vienna, Vienna, Austria;Department of Dermatology, Medical University of Vienna, Vienna, Austria;Department of Medicine I, Institute of Cancer Research, Medical University of Vienna, Austria; Christian Doppler Laboratory for the Diagnosis and Regeneration of Cardiac and Thoracic Diseases, Medical University Vienna, Vienna, Austria

关键词: Proteome profiling;    Primary human cells;    Tumor-stroma interactions;    Inflammatory activation;    Fibroblasts;   

Others  :  1092795
DOI  :  10.1186/1559-0275-11-41

 received in 2014-09-01, accepted in 2014-10-17,  发布年份 2014

【 摘 要 】

Background

Fibroblasts are mesenchymal stromal cells which occur in all tissue types. While their main function is related to ECM production and physical support, they are also important players in wound healing, and have further been recognized to be able to modulate inflammatory processes and support tumor growth. Fibroblasts can display distinct phenotypes, depending on their tissue origin, as well as on their functional state.

Results

In order to contribute to the proteomic characterization of fibroblasts, we have isolated primary human fibroblasts from human skin, lung and bone marrow and generated proteome profiles of these cells by LC-MS/MS. Comparative proteome profiling revealed characteristic differences therein, which seemed to be related to the cell’s tissue origin. Furthermore, the cells were treated in vitro with the pro-inflammatory cytokine IL-1beta. While all fibroblasts induced the secretion of Interleukins IL-6 and IL-8 and the chemokine GRO-alpha, other inflammation-related proteins were up-regulated in an apparently tissue-dependent manner. Investigating fibroblasts from tumorous tissues of skin, lung and bone marrow with respect to such inflammation-related proteins revealed hardly any conformity but rather individual and tumor type-related variations. However, apparent up-regulation of IGF-II, PAI-1 and PLOD2 was observed in melanoma-, lung adenocarcinoma- and multiple myeloma-associated fibroblasts, as well as in hepatocellular carcinoma-associated fibroblasts.

Conclusions

Inflammation-related proteome alterations of primary human fibroblasts were determined by the analysis of IL-1beta treated cells. Tumor-associated fibroblasts from different tissue types hardly showed signs of acute inflammation but displayed characteristic functional aberrations potentially related to chronic inflammation. The present data suggest that the state of the tumor microenvironment is relevant for tumor progression and targeted treatment of tumor-associated fibroblasts may support anti-cancer strategies.

【 授权许可】

   
2014 Slany et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

【 参考文献 】

• [1]Flavell SJ, Hou TZ, Lax S, Filer AD, Salmon M, Buckley CD: Fibroblasts as novel therapeutic targets in chronic inflammation. Br J Pharmacol 2008, 153(Suppl 1):S241-S246.
• [2]Buckley CD, Pilling D, Lord JM, Akbar AN, Scheel-Toellner D, Salmon M: Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation. Trends Immunol 2001, 22:199-204.
• [3]Naylor AJ, Filer A, Buckley CD: The role of stromal cells in the persistence of chronic inflammation. Clin Exp Immunol 2013, 171:30-35.
• [4]Kalluri R, Zeisberg M: Fibroblasts in cancer. Nat Rev Can 2006, 6:392-401.
• [5]Hinz B, Phan SH, Thannickal VJ, Prunotto M, Desmouliere A, Varga J, De Wever O, Mareel M, Gabbiani G: Recent developments in myofibroblast biology: paradigms for connective tissue remodeling. Am J Pathol 2012, 180:1340-1355.
• [6]Marsh T, Pietras K, McAllister SS: Fibroblasts as architects of cancer pathogenesis. Biochim Biophys Acta 1832, 2013:1070-1078.
• [7]Bissell MJ, Hines WC: Why don’t we get more cancer? A proposed role of the microenvironment in restraining cancer progression. Nat Med 2011, 17:320-329.
• [8]Hanahan D, Weinberg RA: Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
• [9]De Wever O, Demetter P, Mareel M, Bracke M: Stromal myofibroblasts are drivers of invasive cancer growth. Int J Cancer 2008, 123:2229-2238.
• [10]Hadler-Olsen E, Winberg JO, Uhlin-Hansen L: Matrix metalloproteinases in cancer: their value as diagnostic and prognostic markers and therapeutic targets. Tumour Biol 2013, 34:2041-2051.
• [11]Sugimoto H, Mundel TM, Kieran MW, Kalluri R: Identification of fibroblast heterogeneity in the tumor microenvironment. Cancer Biol Ther 2006, 5:1640-1646.
• [12]Pilling D, Fan T, Huang D, Kaul B, Gomer RH: Identification of markers that distinguish monocyte-derived fibrocytes from monocytes, macrophages, and fibroblasts. PloS one 2009, 4:e7475.
• [13]Rinn JL, Bondre C, Gladstone HB, Brown PO, Chang HY: Anatomic demarcation by positional variation in fibroblast gene expression programs. PLoS Genetics 2006, 2:e119.
• [14]Chang HY, Chi JT, Dudoit S, Bondre C, van de Rijn M, Botstein D, Brown PO: Diversity, topographic differentiation, and positional memory in human fibroblasts. Proc Natl Acad Sci U S A 2002, 99:12877-12882.
• [15]Postlethwaite AE, Shigemitsu H, Kanangat S: Cellular origins of fibroblasts: possible implications for organ fibrosis in systemic sclerosis. Curr Opin Rheumatol 2004, 16:733-738.
• [16]Paulitschke V, Gruber S, Hofstatter E, Haudek-Prinz V, Klepeisz P, Schicher N, Jonak C, Petzelbauer P, Pehamberger H, Gerner C, Kunstfeld R: Proteome analysis identified the PPARgamma ligand 15d-PGJ2 as a novel drug inhibiting melanoma progression and interfering with tumor-stroma interaction. PloS one 2012, 7:e46103.
• [17]Slany A, Haudek-Prinz V, Meshcheryakova A, Bileck A, Lamm W, Zielinski C, Gerner C, Drach J: Extracellular Matrix Remodeling by Bone Marrow Fibroblast-like Cells Correlates with Disease Progression in Multiple Myeloma. J Proteome Res 2014, 13:844-854.
• [18]Slany A, Haudek-Prinz V, Zwickl H, Stattner S, Grasl-Kraupp B, Gerner C: Myofibroblasts are important contributors to human hepatocellular carcinoma: Evidence for tumor promotion by proteome profiling. Electrophoresis 2013, 34:3315-3325.
• [19]Rothlein R, Mainolfi EA, Kishimoto TK: Treatment of inflammation with anti-ICAM-1. Res Immunol 1993, 144:735-739. discussion 754-762
• [20]De Boeck A, Hendrix A, Maynard D, Van Bockstal M, Daniels A, Pauwels P, Gespach C, Bracke M, De Wever O: Differential secretome analysis of cancer-associated fibroblasts and bone marrow-derived precursors to identify microenvironmental regulators of colon cancer progression. Proteomics 2013, 13:379-388.
• [21]Slany A, Paulitschke V, Haudek-Prinz V, Meshcheryakova A, Gerner C: Determination of cell type-specific proteome signatures of primary human leukocytes, endothelial cells, keratinocytes, hepatocytes, fibroblasts and melanocytes by comparative proteome profiling. Electrophoresis 2014, 35:1428-1438.
• [22]Salza R, Peysselon F, Chautard E, Faye C, Moschcovich L, Weiss T, Perrin-Cocon L, Lotteau V, Kessler E, Ricard-Blum S: Extended interaction network of procollagen C-proteinase enhancer-1 in the extracellular matrix. Biochem J 2014, 457:137-149.
• [23]Kato A, Okamoto O, Ishikawa K, Sumiyoshi H, Matsuo N, Yoshioka H, Nomizu M, Shimada T, Fujiwara S: Dermatopontin interacts with fibronectin, promotes fibronectin fibril formation, and enhances cell adhesion. J Biol Chem 2011, 286:14861-14869.
• [24]Denk AE, Braig S, Schubert T, Bosserhoff AK: Slit3 inhibits activator protein 1-mediated migration of malignant melanoma cells. Int J Mol Med 2011, 28:721-726.
• [25]Bedekovics J, Kiss A, Beke L, Karolyi K, Mehes G: Platelet derived growth factor receptor-beta (PDGFRbeta) expression is limited to activated stromal cells in the bone marrow and shows a strong correlation with the grade of myelofibrosis. Virchows Arch 2013, 463:57-65.
• [26]Donovan J, Shiwen X, Norman J, Abraham D: Platelet-derived growth factor alpha and beta receptors have overlapping functional activities towards fibroblasts. Fibrogenesis Tissue Repair 2013, 6:10. BioMed Central Full Text
• [27]Halfon S, Abramov N, Grinblat B, Ginis I: Markers distinguishing mesenchymal stem cells from fibroblasts are downregulated with passaging. Stem Cells Dev 2011, 20:53-66.
• [28]Hida Y, Hamada J: Differential expressions of matrix metalloproteinases, a disintegrin and metalloproteinases, and a disintegrin and metalloproteinases with thrombospondin motifs and their endogenous inhibitors among histologic subtypes of lung cancers. Anticancer Agents Med Chem 2012, 12:744-752.
• [29]Denkers IA, Beelen RH, Ossenkoppele GJ, De Jong-de Boer AJ, Langenhuijsen MM: Differences of cellular composition and adhesion molecule expression in “leukemic” as compared with “normal” human long-term bone marrow cultures. Ann Hematol 1992, 64:210-216.
• [30]Novince CM, Koh AJ, Michalski MN, Marchesan JT, Wang J, Jung Y, Berry JE, Eber MR, Rosol TJ, Taichman RS, McCauley LK: Proteoglycan 4, a novel immunomodulatory factor, regulates parathyroid hormone actions on hematopoietic cells. Am J Pathol 2011, 179:2431-2442.
• [31]Novince CM, Michalski MN, Koh AJ, Sinder BP, Entezami P, Eber MR, Pettway GJ, Rosol TJ, Wronski TJ, Kozloff KM, McCauley LK: Proteoglycan 4: a dynamic regulator of skeletogenesis and parathyroid hormone skeletal anabolism. J Bone Miner Res 2012, 27:11-25.
• [32]Bae S, Park CW, Son HK, Ju HK, Paik D, Jeon CJ, Koh GY, Kim J, Kim H: Fibroblast activation protein alpha identifies mesenchymal stromal cells from human bone marrow. Br J Haematol 2008, 142:827-830.
• [33]Hu Q, Guo C, Li Y, Aronow BJ, Zhang J: LMO7 mediates cell-specific activation of the Rho-myocardin-related transcription factor-serum response factor pathway and plays an important role in breast cancer cell migration. Mol Cell Biol 2011, 31:3223-3240.
• [34]Nakatani K, Okuyama H, Shimahara Y, Saeki S, Kim DH, Nakajima Y, Seki S, Kawada N, Yoshizato K: Cytoglobin/STAP, its unique localization in splanchnic fibroblast-like cells and function in organ fibrogenesis. Lab Invest 2004, 84:91-101.
• [35]Yan C, Ding X, Wu L, Yu M, Qu P, Du H: Stat3 downstream gene product chitinase 3-like 1 is a potential biomarker of inflammation-induced lung cancer in multiple mouse lung tumor models and humans. PloS one 2013, 8:e61984.
• [36]Bell SM, Schreiner CM, Wert SE, Mucenski ML, Scott WJ, Whitsett JA: R-spondin 2 is required for normal laryngeal-tracheal, lung and limb morphogenesis. Development 2008, 135:1049-1058.
• [37]Foronjy R, Imai K, Shiomi T, Mercer B, Sklepkiewicz P, Thankachen J, Bodine P, D’Armiento J: The divergent roles of secreted frizzled related protein-1 (SFRP1) in lung morphogenesis and emphysema. Am J Pathol 2010, 177:598-607.
• [38]Groffen AJ, Buskens CA, Van Kuppevelt TH, Veerkamp JH, Monnens LA, van den Heuvel LP: Primary structure and high expression of human agrin in basement membranes of adult lung and kidney. Eur J Biochem 1998, 254:123-128.
• [39]Nguyen G, Delarue F, Burckle C, Bouzhir L, Giller T, Sraer JD: Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J Clin Invest 2002, 109:1417-1427.
• [40]Gallagher PE, Cook K, Soto-Pantoja D, Menon J, Tallant EA: Angiotensin peptides and lung cancer. Curr Cancer Drug Targets 2011, 11:394-404.
• [41]Liao W, Bao Z, Cheng C, Mok YK, Wong WS: Dendritic cell-derived interferon-gamma-induced protein mediates tumor necrosis factor-alpha stimulation of human lung fibroblasts. Proteomics 2008, 8:2640-2650.
• [42]Brinckmann J, Kim S, Wu J, Reinhardt DP, Batmunkh C, Metzen E, Notbohm H, Bank RA, Krieg T, Hunzelmann N: Interleukin 4 and prolonged hypoxia induce a higher gene expression of lysyl hydroxylase 2 and an altered cross-link pattern: important pathogenetic steps in early and late stage of systemic scleroderma? Matrix Biol 2005, 24:459-468.
• [43]Wu J, Reinhardt DP, Batmunkh C, Lindenmaier W, Far RK, Notbohm H, Hunzelmann N, Brinckmann J: Functional diversity of lysyl hydroxylase 2 in collagen synthesis of human dermal fibroblasts. Exp Cell Res 2006, 312:3485-3494.
• [44]Bock O, Hoftmann J, Theophile K, Hussein K, Wiese B, Schlue J, Kreipe H: Bone morphogenetic proteins are overexpressed in the bone marrow of primary myelofibrosis and are apparently induced by fibrogenic cytokines. Am J Pathol 2008, 172:951-960.
• [45]Brentnall TA: Arousal of cancer-associated stromal fibroblasts: palladin-activated fibroblasts promote tumor invasion. Cell Adh Migr 2012, 6:488-494.
• [46]Ronty MJ, Leivonen SK, Hinz B, Rachlin A, Otey CA, Kahari VM, Carpen OM: Isoform-specific regulation of the actin-organizing protein palladin during TGF-beta1-induced myofibroblast differentiation. J Invest Dermatol 2006, 126:2387-2396.
• [47]Xin H, Pereira-Smith OM, Choubey D: Role of IFI 16 in cellular senescence of human fibroblasts. Oncogene 2004, 23:6209-6217.
• [48]Li T, Diner BA, Chen J, Cristea IM: Acetylation modulates cellular distribution and DNA sensing ability of interferon-inducible protein IFI16. Proc Natl Acad Sci U S A 2012, 109:10558-10563.
• [49]Sponza S, De Andrea M, Mondini M, Gugliesi F, Gariglio M, Landolfo S: Role of the interferon-inducible IFI16 gene in the induction of ICAM-1 by TNF-alpha. Cell Immunol 2009, 257:55-60.
• [50]Anisowicz A, Messineo M, Lee SW, Sager R: An NF-kappa B-like transcription factor mediates IL-1/TNF-alpha induction of gro in human fibroblasts. J Immunol 1991, 147:520-527.
• [51]Brach MA, Henschler R, Mertelsmann RH, Herrmann F: Regulation of M-CSF expression by M-CSF: role of protein kinase C and transcription factor NF kappa B. Pathobiology 1991, 59:284-288.
• [52]van de Stolpe A, Caldenhoven E, Stade BG, Koenderman L, Raaijmakers JA, Johnson JP, van der Saag PT: 12-O-tetradecanoylphorbol-13-acetate- and tumor necrosis factor alpha-mediated induction of intercellular adhesion molecule-1 is inhibited by dexamethasone. Functional analysis of the human intercellular adhesion molecular-1 promoter. J Biol Chem 1994, 269:6185-6192.
• [53]Basile A, Sica A, D’Aniello E, Breviario F, Garrido G, Castellano M, Mantovani A, Introna M: Characterization of the promoter for the human long pentraxin PTX3. Role of NF-kappaB in tumor necrosis factor-alpha and interleukin-1beta regulation. J Biol Chem 1997, 272:8172-8178.
• [54]Bocian C, Urbanowitz AK, Owens RT, Iozzo RV, Gotte M, Seidler DG: Decorin potentiates interferon-gamma activity in a model of allergic inflammation. J Biol Chem 2013, 288:12699-12711.
• [55]Hayashi N, Yoshimoto T, Izuhara K, Matsui K, Tanaka T, Nakanishi K: T helper 1 cells stimulated with ovalbumin and IL-18 induce airway hyperresponsiveness and lung fibrosis by IFN-gamma and IL-13 production. Proc Natl Acad Sci U S A 2007, 104:14765-14770.
• [56]Nikolaou K, Sarris M, Talianidis I: Molecular pathways: the complex roles of inflammation pathways in the development and treatment of liver cancer. Clin Cancer Res 2013, 19:2810-2816.
• [57]Bozoky B, Savchenko A, Csermely P, Korcsmaros T, Dul Z, Ponten F, Szekely L, Klein G: Novel signatures of cancer-associated fibroblasts. Int J Cancer 2013, 133:286-293.
• [58]Noda T, Yamamoto H, Takemasa I, Yamada D, Uemura M, Wada H, Kobayashi S, Marubashi S, Eguchi H, Tanemura M, Umeshita K, Doki Y, Mori M, Nagano H: PLOD2 induced under hypoxia is a novel prognostic factor for hepatocellular carcinoma after curative resection. Liver Int 2012, 32:110-118.
• [59]Norman J: Fibrosis and progression of autosomal dominant polycystic kidney disease (ADPKD). Biochim Biophys Acta 2011, 1812:1327-1336.
• [60]Maloney EK, McLaughlin JL, Dagdigian NE, Garrett LM, Connors KM, Zhou XM, Blattler WA, Chittenden T, Singh R: An anti-insulin-like growth factor I receptor antibody that is a potent inhibitor of cancer cell proliferation. Cancer Res 2003, 63:5073-5083.
• [61]Bergman D, Halje M, Nordin M, Engstrom W: Insulin-like growth factor 2 in development and disease: a mini-review. Gerontology 2013, 59:240-249.
• [62]Greenall SA, Bentley JD, Pearce LA, Scoble JA, Sparrow LG, Bartone NA, Xiao X, Baxter RC, Cosgrove LJ, Adams TE: Biochemical characterization of individual human glycosylated pro-insulin-like growth factor (IGF)-II and big-IGF-II isoforms associated with cancer. J Biol Chem 2013, 288:59-68.
• [63]Breuhahn K, Schirmacher P: Reactivation of the insulin-like growth factor-II signaling pathway in human hepatocellular carcinoma. World J Gastroenterol 2008, 14:1690-1698.
• [64]Jelinek DF, Witzig TE, Arendt BK: A role for insulin-like growth factor in the regulation of IL-6-responsive human myeloma cell line growth. J Immunol 1997, 159:487-496.
• [65]Barron DA, Rowley DR: The reactive stroma microenvironment and prostate cancer progression. Endocr Relat Cancer 2012, 19:R187-R204.
• [66]Gundacker NC, Haudek VJ, Wimmer H, Slany A, Griss J, Bochkov V, Zielinski C, Wagner O, Stockl J, Gerner C: Cytoplasmic proteome and secretome profiles of differently stimulated human dendritic cells. J Proteome Res 2009, 8:2799-2811.
• [67]Mortz E, Krogh TN, Vorum H, Gorg A: Improved silver staining protocols for high sensitivity protein identification using matrix-assisted laser desorption/ionization-time of flight analysis. Proteomics 2001, 1:1359-1363.
• [68]Slany A, Haudek VJ, Gundacker NC, Griss J, Mohr T, Wimmer H, Eisenbauer M, Elbling L, Gerner C: Introducing a new parameter for quality control of proteome profiles: consideration of commonly expressed proteins. Electrophoresis 2009, 30:1306-1328.
• [69]Nesvizhskii AI, Keller A, Kolker E, Aebersold R: A statistical model for identifying proteins by tandem mass spectrometry. Anal Chem 2003, 75:4646-4658.
• [70]Griss J, Gerner C: GPDE: a biological view on PRIDE. J Proteomics Bioinform 2009, 2:167-174.
• [71]Griss J, Haudek-Prinz V, Gerner C: GPDE: A biological proteomic database for biomarker discovery and evaluation. Proteomics 2011, 11:1000-1004.
• [72]Wimmer H, Gundacker NC, Griss J, Haudek VJ, Stattner S, Mohr T, Zwickl H, Paulitschke V, Baron DM, Trittner W, Kubicek M, Bayer E, Slany A, Gerner C: Introducing the CPL/MUW proteome database: interpretation of human liver and liver cancer proteome profiles by referring to isolated primary cells. Electrophoresis 2009, 30:2076-2089.
• [73]Ishihama Y, Oda Y, Tabata T, Sato T, Nagasu T, Rappsilber J, Mann M: Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein. Mol Cell Proteomics 2005, 4:1265-1272.